Respiratory syncytial virus (RSV): Burden estimation and the development of a monoclonal antibody-based point of care diagnostic
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 600
- 试验地点
- 1
- 主要终点
- Understanding the burden of RSV in the community
研究概览
简要总结
In India, there is not enough documentation on RSV epidemiology/ disease burden. This may hinder and delay the decision-making process for evidence-based policy decisions on any new RSV vaccine/immunotherapies. Here we plan to determine the proportion of RSV among respiratory infections across the geographic regions and in patients with various co-morbidities to provide a comprehensive representation of the burden of RSV. Establishing a point-of-care diagnosis in the health care setting can improve clinical management of the patient.
Study Objectives:
To estimate the burden of respiratory syncytial virus disease among different age groups
To study the molecular epidemiology of respiratory syncytial virus and to evaluate the severity associated with genotype
Development of a monoclonal antibody-based rapid diagnostic kit for respiratory syncytial virus
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 1.00 Day(s) 至 80.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients with ILI and SARI symptoms admitted to KMC Manipal.
排除标准
- •Patients with chronic illness.
结局指标
主要结局
Understanding the burden of RSV in the community
时间窗: Baseline
次要结局
- Predict the Seasonality of RSV(36 Months)
研究者
Anup Jayaram
Manipal Institute of Virology, Manipal Academy of Higher Education